F8 and hemophilia A: The most striking finding was that inhibitors in patients with moderate hemophilia A developed after significantly more EDs: median 75 EDs compared with 27 EDs in those with 6% to 10% endogenous FVIII activity and 25 EDs in those with 11% to 40% endogenous FVIII activity (P < .001).